A study evaluating association between biodistribution of rituximab and clinical response in patients with rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Rituximab (Primary) ; Zirconium-89-rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics; Therapeutic Use
- 15 Dec 2017 New trial record